Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
2017 Standout
Works of David Assouline being referenced
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
2001
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Assouline | 180 | 223 | 118 | 22 | 403 | |
| Jill Moormeier | 224 | 126 | 46 | 24 | 450 | |
| S.A.M. van de Schans | 240 | 205 | 110 | 26 | 451 | |
| Christine Laidlaw | 155 | 116 | 79 | 21 | 344 | |
| Rafael Carrión | 165 | 235 | 91 | 20 | 367 | |
| Benjamin M. Parsons | 199 | 250 | 91 | 33 | 435 | |
| Dan Painter | 174 | 245 | 39 | 10 | 443 | |
| Lee Chun Park | 109 | 106 | 94 | 30 | 360 | |
| William G. Swartz | 165 | 259 | 23 | 12 | 457 | |
| Robert Schou Pedersen | 155 | 194 | 39 | 34 | 425 | |
| V. Silingardi | 111 | 139 | 61 | 27 | 371 |
All Works
Loading papers...